Trial Profile
A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Oral Administration of ASP7991 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs ASP 7991 (Primary)
- Indications Secondary hyperparathyroidism
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 14 Apr 2014 New trial record